Lindbrook Capital, LLC Charles River Laboratories International, Inc. Transaction History

Lindbrook Capital, LLC

$1.09 Billion
Q4 2024

A detailed history of Lindbrook Capital, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Lindbrook Capital, LLC holds 160 shares of CRL stock, worth $26,083. This represents 0.0% of its overall portfolio holdings.

Number of Shares

160

Previous 164 2.44%

Holding current value

$26,083

Previous $32,000 9.38%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 06, 2025	SELL	$178.58 - $220.69 $714 - $882	-4 Reduced 2.44%	160 $29,000
Q3 2024 Nov 01, 2024	BUY	$187.96 - $245.29 $9,398 - $12,264	50 Added 43.86%	164 $32,000
Q1 2024 Apr 25, 2024	BUY	$203.52 - $273.43 $814 - $1,093	4 Added 3.64%	114 $30,000
Q4 2023 Jan 31, 2024	BUY	$164.52 - $238.84 $4,277 - $6,209	26 Added 30.95%	110 $26,000
Q3 2023 Oct 25, 2023	SELL	$194.44 - $217.61 $9,333 - $10,445	-48 Reduced 36.36%	84 $16,000
Q2 2023 Jul 28, 2023	BUY	$183.71 - $210.25 $11,941 - $13,666	65 Added 97.01%	132 $27,000
Q1 2023 Apr 26, 2023	SELL	$191.89 - $259.92 $2,494 - $3,378	-13 Reduced 16.25%	67 $13,000
Q4 2022 Jan 24, 2023	SELL	$197.11 - $250.07 $8,081 - $10,252	-41 Reduced 33.88%	80 $0
Q3 2022 Nov 10, 2022	BUY	$182.44 - $250.54 $7,297 - $10,021	40 Added 49.38%	121 $24,000
Q2 2022 Aug 01, 2022	BUY	$204.13 - $302.4 $1,837 - $2,721	9 Added 12.5%	81 $17,000
Q1 2022 Apr 21, 2022	SELL	$255.51 - $362.11 $3,321 - $4,707	-13 Reduced 15.29%	72 $20,000
Q4 2021 Jan 18, 2022	SELL	$351.38 - $448.68 $2,811 - $3,589	-8 Reduced 8.6%	85 $32,000
Q3 2021 Nov 05, 2021	SELL	$372.64 - $458.3 $1,863 - $2,291	-5 Reduced 5.1%	93 $38,000
Q2 2021 Jul 27, 2021	BUY	$294.17 - $371.65 $2,941 - $3,716	10 Added 11.36%	98 $36,000
Q1 2021 Apr 28, 2021	BUY	$249.67 - $299.48 $3,745 - $4,492	15 Added 20.55%	88 $26,000
Q4 2020 Jan 27, 2021	BUY	$222.0 - $252.62 $666 - $757	3 Added 4.29%	73 $18,000
Q3 2020 Nov 03, 2020	BUY	$175.56 - $226.45 $526 - $679	3 Added 4.48%	70 $16,000
Q2 2020 Jul 27, 2020	SELL	$118.84 - $189.72 $2,020 - $3,225	-17 Reduced 20.24%	67 $12,000
Q1 2020 Apr 22, 2020	BUY	$98.9 - $178.34 $791 - $1,426	8 Added 10.53%	84 $11,000
Q3 2019 Oct 31, 2019	BUY	$125.07 - $143.67 $2,126 - $2,442	17 Added 28.81%	76 $10,000
Q4 2018 Feb 07, 2019	BUY	$105.09 - $137.23 $6,200 - $8,096	59 New	59 $6,000

Others Institutions Holding CRL

# of Institutions

708

Shares Held

53.9M

Call Options Held

122K

Put Options Held

239K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.29B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.

Account

Lindbrook Capital, LLC Charles River Laboratories International, Inc. Transaction History